Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound Tops Wegovy for Weight Loss
In new trial, Zepbound bests Wegovy for weight loss
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
1h
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
STAT
6h
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming the FDA, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
BioPharma Dive
1d
Diabetes advocacy group discourages use of compounded GLP-1 drugs
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...
6d
Dr. Roach: In two cases, Zepbound provides great benefit to overall health
Dear S.R.: Tirzepatide (Zepbound), like semaglutide, is a prescription medication originally used for diabetes but now ...
1d
Weight-loss drugs deliver life-changing health benefits - and big profits
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Opinion
1d
Opinion
A Thumb on the Scale for Wegovy
Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Wegovy
Eli Lilly
Novo Nordisk
Amgen
Glucagon-like peptide-1
Feedback